LI ALBERT has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are ZHU JIA BEI, MD APTUS INC and COYNE IP HOLDINGS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | China | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Basic materials chemistry | |
#5 | Foods and drinks | |
#6 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Microorganisms | |
#3 | Measuring microorganism processes | |
#4 | Preservation of human bodies | |
#5 | Medical preparations | |
#6 | Climate change adaptation technologies | |
#7 | Therapeutic chemical compounds | |
#8 | Foods | |
#9 | Special foods | |
#10 | Food shaping |
# | Name | Total Patents |
---|---|---|
#1 | Li Albert | 13 |
Publication | Filing date | Title |
---|---|---|
WO2021042071A1 | Recovery of hepatic function of cultured hepatocytes | |
US2019274342A1 | Yolkless hard boilded egg product | |
EP3759236A1 | Isolated intestinal mucosa and uses thereof | |
EP3519817A1 | In vitro drug metabolism reagent and uses thereof | |
US2019218588A1 | Novel cell culture method, cell culture system and uses thereof | |
US2015072423A1 | Cell preparation method |